Lipase inhibiting compositions
US6703369B1 · kind B1 · utility
3Cited by
3References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 13, 2000 |
| Grant date | Mar 9, 2004 |
| Priority date | — |
| Expiry date | Dec 15, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition contains at least one inhibitor of lipases and at least one fatty acid ester of polyol. In this composition, the fatty acid ester has a melting point above the body temperature and the polyols are chosen from the group consisting of sugars, sugar derivatives, and mixtures thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.